1. Home
  2. ACXP vs PIII Comparison

ACXP vs PIII Comparison

Compare ACXP & PIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACXP
  • PIII
  • Stock Information
  • Founded
  • ACXP 2017
  • PIII 2015
  • Country
  • ACXP United States
  • PIII United States
  • Employees
  • ACXP N/A
  • PIII N/A
  • Industry
  • ACXP Biotechnology: Pharmaceutical Preparations
  • PIII Medical/Nursing Services
  • Sector
  • ACXP Health Care
  • PIII Health Care
  • Exchange
  • ACXP Nasdaq
  • PIII Nasdaq
  • Market Cap
  • ACXP 31.4M
  • PIII 32.2M
  • IPO Year
  • ACXP 2021
  • PIII N/A
  • Fundamental
  • Price
  • ACXP $0.77
  • PIII $0.19
  • Analyst Decision
  • ACXP Strong Buy
  • PIII Buy
  • Analyst Count
  • ACXP 1
  • PIII 3
  • Target Price
  • ACXP $12.00
  • PIII $2.38
  • AVG Volume (30 Days)
  • ACXP 479.2K
  • PIII 5.5M
  • Earning Date
  • ACXP 03-14-2025
  • PIII 03-27-2025
  • Dividend Yield
  • ACXP N/A
  • PIII N/A
  • EPS Growth
  • ACXP N/A
  • PIII N/A
  • EPS
  • ACXP N/A
  • PIII N/A
  • Revenue
  • ACXP N/A
  • PIII $1,476,630,000.00
  • Revenue This Year
  • ACXP N/A
  • PIII $21.45
  • Revenue Next Year
  • ACXP N/A
  • PIII N/A
  • P/E Ratio
  • ACXP N/A
  • PIII N/A
  • Revenue Growth
  • ACXP N/A
  • PIII 25.38
  • 52 Week Low
  • ACXP $0.68
  • PIII $0.17
  • 52 Week High
  • ACXP $3.35
  • PIII $1.22
  • Technical
  • Relative Strength Index (RSI)
  • ACXP 42.04
  • PIII 38.13
  • Support Level
  • ACXP $0.70
  • PIII $0.17
  • Resistance Level
  • ACXP $0.87
  • PIII $0.20
  • Average True Range (ATR)
  • ACXP 0.06
  • PIII 0.02
  • MACD
  • ACXP 0.00
  • PIII -0.00
  • Stochastic Oscillator
  • ACXP 22.09
  • PIII 19.64

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.

About PIII P3 Health Partners Inc.

P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.

Share on Social Networks: